Bretylium Tosylate Injection

28 June 2004

Estimated Resupply Dates

Bretylium tosylate injection has been discontinued by all manufacturers. Product has been unavailable to many centers since 1999. The drug is no longer listed as a potential therapy in the American Heart Association 2001 ACLS guidelines.

Related Shortages

• Digoxin Oral Products
• Disopyramide
• Inamrinone Injection
• Mexiletine Capsules

Updated

University of Utah, Drug Information Service, June 28, 2004

Back to Drug Shortage Product Bulletins